These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 10735393

  • 21. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.
    Bilousova T, Miller CA, Poon WW, Vinters HV, Corrada M, Kawas C, Hayden EY, Teplow DB, Glabe C, Albay R, Cole GM, Teng E, Gylys KH.
    Am J Pathol; 2016 Jan; 186(1):185-98. PubMed ID: 26718979
    [Abstract] [Full Text] [Related]

  • 22. Elevated Tau PET Signal Depends on Abnormal Amyloid Levels and Correlates with Cognitive Impairment in Elderly Persons without Dementia.
    Zhang RQ, Chen SD, Shen XN, Yang YX, Lu JY, Cui M, Zuo CT, Dong Q, Tan L, Yu JT, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2020 Jan; 78(1):395-404. PubMed ID: 32986669
    [Abstract] [Full Text] [Related]

  • 23. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.
    Mielke MM, Hagen CE, Wennberg AMV, Airey DC, Savica R, Knopman DS, Machulda MM, Roberts RO, Jack CR, Petersen RC, Dage JL.
    JAMA Neurol; 2017 Sep 01; 74(9):1073-1080. PubMed ID: 28692710
    [Abstract] [Full Text] [Related]

  • 24. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ, Largo-Barrientos P, Uytterhoeven V, Reichwald J, Rabe S, Vandenberghe R, von Arnim CAF, Tousseyn T, Feederle R, Giudici C, Willem M, Staufenbiel M, Thal DR.
    Acta Neuropathol; 2019 Dec 01; 138(6):913-941. PubMed ID: 31414210
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
    Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC, Ances BM.
    JAMA Neurol; 2016 Sep 01; 73(9):1070-7. PubMed ID: 27454922
    [Abstract] [Full Text] [Related]

  • 26. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.
    Arch Neurol; 2009 Mar 01; 66(3):382-9. PubMed ID: 19273758
    [Abstract] [Full Text] [Related]

  • 27. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ.
    JAMA Neurol; 2018 Feb 01; 75(2):227-235. PubMed ID: 29228071
    [Abstract] [Full Text] [Related]

  • 28. Aβ-amyloid and Tau Imaging in Dementia.
    Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC.
    Semin Nucl Med; 2017 Jan 01; 47(1):75-88. PubMed ID: 27987560
    [Abstract] [Full Text] [Related]

  • 29. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.
    Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS.
    Arch Neurol; 2012 Oct 01; 69(10):1326-31. PubMed ID: 22825369
    [Abstract] [Full Text] [Related]

  • 30. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ.
    Ann Neurol; 2019 Feb 01; 85(2):259-271. PubMed ID: 30549331
    [Abstract] [Full Text] [Related]

  • 31. Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques.
    Tomidokoro Y, Lashley T, Rostagno A, Neubert TA, Bojsen-Møller M, Braendgaard H, Plant G, Holton J, Frangione B, Révész T, Ghiso J.
    J Biol Chem; 2005 Nov 04; 280(44):36883-94. PubMed ID: 16091362
    [Abstract] [Full Text] [Related]

  • 32. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Någren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO.
    Arch Neurol; 2008 Oct 04; 65(10):1304-9. PubMed ID: 18695050
    [Abstract] [Full Text] [Related]

  • 33. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.
    Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC.
    Neurology; 2004 Mar 23; 62(6):925-31. PubMed ID: 15037694
    [Abstract] [Full Text] [Related]

  • 34. Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.
    Michalski B, Corrada MM, Kawas CH, Fahnestock M.
    Neurobiol Aging; 2015 Dec 23; 36(12):3130-3139. PubMed ID: 26410307
    [Abstract] [Full Text] [Related]

  • 35. Early detection of amyloid load using 18F-florbetaben PET.
    Bullich S, Roé-Vellvé N, Marquié M, Landau SM, Barthel H, Villemagne VL, Sanabria Á, Tartari JP, Sotolongo-Grau O, Doré V, Koglin N, Müller A, Perrotin A, Jovalekic A, De Santi S, Tárraga L, Stephens AW, Rowe CC, Sabri O, Seibyl JP, Boada M.
    Alzheimers Res Ther; 2021 Mar 27; 13(1):67. PubMed ID: 33773598
    [Abstract] [Full Text] [Related]

  • 36. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.
    Yu L, Boyle PA, Leurgans S, Schneider JA, Bennett DA.
    Neurobiol Aging; 2014 Apr 27; 35(4):819-26. PubMed ID: 24199961
    [Abstract] [Full Text] [Related]

  • 37. Intraneuronal Abeta42 accumulation in human brain.
    Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR.
    Am J Pathol; 2000 Jan 27; 156(1):15-20. PubMed ID: 10623648
    [Abstract] [Full Text] [Related]

  • 38. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ, Devous MD, Kennedy I, Navitsky M, Lu M, Galante N, Salloway S, Doraiswamy PM, Southekal S, Arora AK, McGeehan A, Lim NC, Xiong H, Truocchio SP, Joshi AD, Shcherbinin S, Teske B, Fleisher AS, Mintun MA.
    Brain; 2019 Jun 01; 142(6):1723-1735. PubMed ID: 31009046
    [Abstract] [Full Text] [Related]

  • 39. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE, Sekhar N, Rajamma RG, Marathakam A, Al Mamun A, Uddin MS, Mathew B.
    Curr Protein Pept Sci; 2020 Jun 01; 21(12):1164-1173. PubMed ID: 32957903
    [Abstract] [Full Text] [Related]

  • 40. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA.
    Neuroimage; 2017 Mar 01; 148():296-304. PubMed ID: 27989773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.